Healthcare provider profile · identity verified

Aaron Ray Stapley, D.O.

Family Practice · BRIGHAM CITY, UT · NPI 1427496918

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1281	395
Amlodipine Besylate	Amlodipine Besylate	666	216
Levothyroxine Sodium	Levothyroxine Sodium	634	177
Lisinopril	Lisinopril	519	170
Losartan Potassium	Losartan Potassium	491	159
Omeprazole	Omeprazole	423	142
Pantoprazole Sodium	Pantoprazole Sodium	290	100
Gabapentin	Gabapentin	286	98
Metoprolol Succinate	Metoprolol Succinate	283	95
Hydrochlorothiazide	Hydrochlorothiazide	278	95
Rosuvastatin Calcium	Rosuvastatin Calcium	278	90
Tamsulosin Hcl	Tamsulosin Hcl	276	102
Simvastatin	Simvastatin	270	89
Metformin Hcl	Metformin Hcl	254	83
Metoprolol Tartrate	Metoprolol Tartrate	237	70
Albuterol Sulfate Hfa	Albuterol Sulfate	234	95
Trazodone Hcl	Trazodone Hcl	179	69
Allopurinol	Allopurinol	167	50
Duloxetine Hcl	Duloxetine Hcl	149	45
Alendronate Sodium	Alendronate Sodium	142	44
Metformin Hcl Er	Metformin Hcl	142	48
Pravastatin Sodium	Pravastatin Sodium	140	40
Fluticasone Propionate	Fluticasone Propionate	133	61
Atenolol	Atenolol	131	40
Furosemide	Furosemide	120	42
Eliquis	Apixaban	117	33
Clopidogrel	Clopidogrel Bisulfate	112	35
Carvedilol	Carvedilol	108	35
Fluoxetine Hcl	Fluoxetine Hcl	104	34
Montelukast Sodium	Montelukast Sodium	103	35
Potassium Chloride	Potassium Chloride	99	38
Glipizide Er	Glipizide	96	34
Famotidine	Famotidine	86	30
Sertraline Hcl	Sertraline Hcl	83	28
Doxycycline Monohydrate	Doxycycline Monohydrate	80	65
Ropinirole Hcl	Ropinirole Hcl	77	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	75	32
Zolpidem Tartrate	Zolpidem Tartrate	74	26
Lovastatin	Lovastatin	70	22
Escitalopram Oxalate	Escitalopram Oxalate	65	18
Hydroxyzine Hcl	Hydroxyzine Hcl	65	17
Finasteride	Finasteride	60	21
Citalopram Hbr	Citalopram Hydrobromide	59	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	20
Nifedipine Er	Nifedipine	58	18
Warfarin Sodium	Warfarin Sodium	58	14
Ezetimibe	Ezetimibe	55	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	18
Ozempic	Semaglutide	54	14
Valacyclovir	Valacyclovir Hcl	52	20
Trulicity	Dulaglutide	50	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	14
Hydralazine Hcl	Hydralazine Hcl	46	15
Meloxicam	Meloxicam	45	20
Pioglitazone Hcl	Pioglitazone Hcl	45	16
Donepezil Hcl	Donepezil Hcl	43	14
Jardiance	Empagliflozin	42	13
Mirtazapine	Mirtazapine	42	suppressed
Glipizide	Glipizide	40	20
Chlorthalidone	Chlorthalidone	37	12
Triamcinolone Acetonide	Triamcinolone Acetonide	37	23
Synthroid	Levothyroxine Sodium	36	11
Clonidine Hcl	Clonidine Hcl	35	11
Spironolactone	Spironolactone	35	suppressed
Irbesartan	Irbesartan	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Memantine Hcl	Memantine Hcl	33	13
Celecoxib	Celecoxib	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	13
Enalapril Maleate	Enalapril Maleate	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Gemfibrozil	Gemfibrozil	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	16
Diclofenac Sodium	Diclofenac Sodium	27	16
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	11
Xarelto	Rivaroxaban	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	24
Hydrocortisone	Hydrocortisone	24	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Ondansetron Odt	Ondansetron	23	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Acyclovir	Acyclovir	22	12
Benazepril Hcl	Benazepril Hcl	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Azithromycin	Azithromycin	21	21
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Prednisone	Prednisone	18	17
Propranolol Hcl	Propranolol Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Estradiol	Estradiol	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Ofloxacin	Ofloxacin	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Baclofen	Baclofen	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Cephalexin	Cephalexin	14	14
Eszopiclone	Eszopiclone	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Clotrimazole	Clotrimazole	13	11
Farxiga	Dapagliflozin Propanediol	13	suppressed
Linzess	Linaclotide	13	suppressed
Naproxen	Naproxen	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	13
Buspirone Hcl	Buspirone Hcl	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Ramipril	Ramipril	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error